Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mattr Announces Conference Call/Webcast to Discuss First Quarter 2024 Results Wednesday, May 15th, 2024 at 9:00AM ET
-
APA Corporation Provides First-Quarter 2024 Supplemental Information and Schedules Results Conference Call for May 2 at 10 a.m. Central Time
-
Koryx Copper Intersects 98.00 M @ 0.43% Cu Eq, Including 4 M @ 1.12% Cu Eq and 2 M @ 1.47% Cu Eq
-
MariMed Partners with Iconic Boston Music Venues
-
Blackwells Files Definitive Proxy Statement for Braemar Hotels & Resorts Inc.’s 2024 Annual Meeting
-
Kura Oncology to Participate in Stifel Targeted Oncology Forum
-
DocNetwork Completes SOC 2 Type 1 and HIPAA Certifications for CampDoc and SchoolDoc Platforms
-
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
-
Blackwells Files Definitive Proxy Statement for Braemar Hotels & Resorts Inc.’s 2024 Annual Meeting
-
Flow Capital Announces a US$2 Million Follow-On Investment in MiniLuxe
-
Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024
-
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
-
Amerigo Reports Strong Q1-2024 Operational Results
-
Dragonfly Energy’s Domestic Battery Manufacturing Validated for Cost Effectiveness and Sustainability
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Auction result of Treasury Bonds - RIKB 26 1015 - RIKB 35 0917
-
Form 8.3 - UK Commercial Property REIT
-
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
-
BioPorto A/S Appoints Chief Legal Officer
-
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
-
Spectral Medical Provides Tigris Trial Update
-
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
-
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
-
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
-
Colliers adds market leader in Philadelphia
-
Surge Copper Outlines Pre-Feasibility Technical Work Programs at Berg and Announces Additional Private Placement for up to $1.0 million
-
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
-
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
-
Operative Announces Adeline, A New AI Platform for Media Companies
-
Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit CLMBR at FIBO Global Fitness, the World's Largest Trade Show for Fitness, Wellness and Health on April 11-14
-
AAMI Announces Ralph Basile Appointed to Philanthropic Activities for the AAMI Foundation
-
Xtract One Technologies Partners with Oak View Group to Secure Co-op Live, Manchester’s New 23,500 Capacity Arena
-
L3Harris Selects Mercury to Provide Solid-State Data Recorders for SDA’s Tranche 2 Tracking Layer Satellites
-
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to May 10, 2024
-
Interactive Strength Inc. (Nasdaq: TRNR) to Exhibit CLMBR at FIBO Global Fitness, the World's Largest Trade Show for Fitness, Wellness and Health on April 11-14
-
PyroGenesis and Constellium Sign Letter of Intent for Large-Scale Plasma Remelting Furnaces
-
Multi Ways Holdings Announces the Sale of Premium SANY Cranes to Meet Growing Market Demand
-
Clearway Energy, Inc. to Report First Quarter 2024 Financial Results on May 9, 2024
-
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
-
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
-
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
-
Constellium and PyroGenesis partner to advance plasma burner technology in aluminium melting process
-
MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
-
Stella-Jones’ Annual and Special Meeting of Shareholders and First-Quarter Results Conference Call
-
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024
-
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
-
BYG4lab®, Innovator of Next Generation Software Suites for Laboratories and Diagnostics, Appoints Tim Bickley as VP Sales US to Spearhead Entry into US market
-
Disclosure of total number of voting rights and number of shares in the capital at March 31, 2024
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc

